bioRxivPhysiology
Predicting hERG repolarization power at 37°C from recordings at room temperature
B. Ribeiro, M. Alameh, J. Montnach, B. Ollivier, S. Gibaud, S. Feliciangeli, F. Lesage, F. Charpentier, G. Loussouarn, M. De Waard, I. Baro
Abstract
Mutations in the KCNH2 gene cause long or short QT syndromes (LQTS or SQTS) predisposing to life-threatening arrhythmias. KCNH2 encodes for the voltage-gated K+ channel hERG involved in the late repolarization phase of the cardiac action potential (AP). For the last decades, sequencing KCNH2 has provided a plethora of variants associated or not with clear pathological cardiac phenotypes. Identifying pathogenic or likely pathogenic variants from the benign ones would provide useful information to clarify the genetic background of LQTS patients and relatives, and to stratify the risk of adverse events. In face of a wide spectrum of hERG biophysical defects, we looked for a way to summarize the net loss or gain of function in a unique index. In a previous work, we defined as the repolarization power the time integral of the K+ currents developed during an AP clamp. Here, with the aim of accelerating the functional characterization of hERG variants using automated patch-clamp, we adapted the AP-clamp protocol to establish, at room temperature, at which the recording success rate is high, a repolarization power index, as reliable and informative as the one measured at physiological temperature. We also illustrate that the repolarization power determined at room temperature is predictive of the repolarization power at physiological temperature for 2 pathogenic hERG variants with different biophysical dysfunctions.
- organism: human
- assay: electrophysiology
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MeTAL enables multiparametric risk prediction for human KCNH2 variants
Bárbara Bruna Ribeiro Oliveira-Mendes, Elouan Voisin, … Rupamanjari Majumder·bioRxiv·May 4, 2026
- Molecular Insights into the Rescue Mechanism of an hERG Activator Against Severe LQT2 Mutations.
Amit Kumawat, Elisa Tavazzani, … Carlo Camilloni·Journal of Biomedical SciencePeer-reviewed·Apr 7, 2025
- Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance
Jaël S. Copier, Marianne Bootsma, … Elisabeth M. Lodder·Human Molecular GeneticsPeer-reviewed·Oct 19, 2022
- Isogenic sets of hiPSC-CMs harboring KCNH2 mutations capture location-related phenotypic differences
K. O. Brandao, L. van den Brink, … R. P. Davis·Stem Cell ReportsPeer-reviewed·Nov 1, 2020
- Expression-System Biases Compromise the Functional Assessment of KCNH2 Variants and Clinical Risk Assessment
Aline Rio, Malak Alameh, … Gildas Loussouarn·bioRxiv·Nov 10, 2026
- Clinical interpretation of KCNH2 variants using a robust PS3/BS3 functional patch clamp assay
Kate L. Thomson, Connie Jiang, … Chai‐Ann Ng·Human Genetics and Genomics AdvancesPeer-reviewed·Jan 19, 2024